Cambridge Investment Research Advisors, Inc. Ark Genomic Revolution ETF (De Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 76,685 shares of ARKG stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,685
Previous 94,117
18.52%
Holding current value
$2.39 Million
Previous $1.95 Million
4.45%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding ARKG
# of Institutions
283Shares Held
19MCall Options Held
3.93MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$107 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$99.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$66.2 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$42.1 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$33.8 Million0.01% of portfolio